Nuogen Pharma’s mission is to deliver the first FDA-approved anti-itch medication for chronic pruritus of unknown origin (CPUO) and other chronic itch conditions.
Duke Leahey
Advertisement
Articles by Duke Leahey
Advertisement
Latest Updated Articles
Nuogen Pharma: Innovation in the fight against itchMarch 30th 2020
Advertisement
Advertisement
Trending on Dermatology Times
1
Dermalogica Enters Medical Aesthetics with FDA-Cleared Microneedling PRO Pen
2
Social Media Mythbusters: Hypochlorous Acid Sprays
3
SkinJect Advances into Registrable Development as Potential First-in-Class Therapy for Gorlin Syndrome
4
STAT6 Degradation by KT-621 Correlates With Itch and Lesion Reduction in AD
5